|
|
||||||||
Ann Thorac Surg 2007;83:1697-1705
© 2007 The Society of Thoracic Surgeons
a Department of Thoracic and Cardiovascular Surgery, University Hospital of Münster, Münster
b Department of Cardiovascular Surgery, University Medical Center of Freiburg, Freiburg, Germany
Accepted for publication January 12, 2007.
* Address correspondence to Dr Etz, Department of Thoracic and Cardiovascular Surgery, University Hospital of Münster, Albert-Schweitzer-Str 33, 48149 Münster, Germany (Email: christian.etz{at}ukmuenster.de).
Presented at the Poster Session of the Forty-second Annual Meeting of The Society of Thoracic Surgeons, Chicago, IL, Jan 30Feb 1, 2006.
Background: Severe pulmonary hypertension refractory to medical treatment is a contraindication to orthotopic heart transplantation in most centers. We report our experience in treating severe pulmonary hypertension with mechanical left ventricular unloading using implantable nonpulsatile left ventricular assist devices (LVAD) with continuous flow properties.
Methods: In ten patients with severe pulmonary hypertension, refractory to medical treatment, an implantable nonpulsatile LVAD was placed for continuous mechanical left ventricular support. Pulmonary hemodynamics were assessed by right heart catheterization prior to and during LVAD implantation, and after orthotopic heart transplantation.
Results: The mean (±SD) interval of nonpulsatile support was 182 (±118) days. Pulmonary artery pressure (mean ± SD) significantly decreased from 42 ± 13 to 24 ± 5 mm Hg (p < 0.005), the transpulmonary gradient (mean ± SD) decreased from 20 ± 6 to 11 ±5 mm Hg (p < 0.005), and the pulmonary vascular resistance (mean ± SD) from 4.8 ± 1.8 to 2.2 ± 0.8 Wood units (p < 0.005) during an interval of one to six months of LVAD support. No significant increases in pulmonary artery pressure, transpulmonary gradient, and pulmonary vascular resistance were observed during an interval of three to six months after orthotopic heart transplantation.
Conclusions: This study supports that LVAD support and continuous nonpulsatile mechanical unloading of the left ventricle can reverse medically unresponsive pulmonary hypertension and render patients eligible for orthotopic heart transplantation.
Related Article
Ann. Thorac. Surg. 2007 83: 1705-1706.
This article has been cited by other articles:
![]() |
R. John, F. Kamdar, K. Liao, M. Colvin-Adams, A. Boyle, and L. Joyce Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy. Ann. Thorac. Surg., October 1, 2008; 86(4): 1227 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Viklicky, I. Netuka, M. Urbanova, M. Adamec, J. Maly, L. Voska, and E. Pokorna Kidney transplantation from a brain-dead heart transplant candidate treated with biventricular assist device: 12-month follow-up NDT Plus, February 1, 2008; 1(1): 34 - 35. [Full Text] [PDF] |
||||
![]() |
P. Hendry Invited commentary Ann. Thorac. Surg., May 1, 2007; 83(5): 1705 - 1706. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |